Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Fears

Showing results (41-50 of 161) with videos related to

Pageof 17
Sort By:
Journal of the National Cancer Institute|December 8, 2005
Re: Sun exposure and mortality from melanomaThomas R Fears, Margaret A Tucker
Biometrics|April 28, 2000
Analysis of a two-stage case-control study with cluster sampling of controls: application to nonmelanoma skin cancerT R Fears, M H Gail
Journal of Toxicology and Environmental Health|November 1, 1977
Response to "use of Statistics when Examining Lifetime Studies in Rodents to Detect Carcinogenicity"T R Fears, R E Tarone
Journal of Environmental Pathology and Toxicology|September 1, 1978
Suggested procedures for reducing the pathology workload in a carcinogen bioassay program, Part IT R Fears, J F Douglas
Statistics in Medicine|December 1, 1990
Optimum allocation of samples in strata-matching case-control studies when cost per sample differs from stratum to stratumJ M Nam, T R Fears
Science (New York, N.Y.)|March 22, 1974
Pathologic evaluation and the blind techniqueT R Fears, M A Schneiderman
Seminars in Thrombosis and Hemostasis|October 1, 1991
Fibrinolytic activity in patients with diabetes mellitus: characterization of the effects of thrombolytic agents on plasma clot lysis in vitroR Fears, R Standring, R Abraham
Drugs|January 1, 1987
Evidence for the progressive uptake of anisoylated plasminogen streptokinase activator complex by clots in human plasma in vitroR Fears, H Ferres, R Standring
Drugs|January 1, 1987
The protective effect of acylation on the stability of anisoylated plasminogen streptokinase activator complex in human plasmaR Fears, H Ferres, R Standring
Thrombosis and Haemostasis|February 28, 1986
Isolation and preliminary characterisation of active B-chain of recombinant tissue-type plasminogen activatorI Dodd, R Fears, J H Robinson
Pageof 17

Showing results (41-50 of 161) with videos related to

Sort By:
Pageof 17
Journal of the National Cancer Institute|December 8, 2005
Re: Sun exposure and mortality from melanomaThomas R Fears, Margaret A Tucker
Biometrics|April 28, 2000
Analysis of a two-stage case-control study with cluster sampling of controls: application to nonmelanoma skin cancerT R Fears, M H Gail
Journal of Toxicology and Environmental Health|November 1, 1977
Response to "use of Statistics when Examining Lifetime Studies in Rodents to Detect Carcinogenicity"T R Fears, R E Tarone
Journal of Environmental Pathology and Toxicology|September 1, 1978
Suggested procedures for reducing the pathology workload in a carcinogen bioassay program, Part IT R Fears, J F Douglas
Statistics in Medicine|December 1, 1990
Optimum allocation of samples in strata-matching case-control studies when cost per sample differs from stratum to stratumJ M Nam, T R Fears
Science (New York, N.Y.)|March 22, 1974
Pathologic evaluation and the blind techniqueT R Fears, M A Schneiderman
Seminars in Thrombosis and Hemostasis|October 1, 1991
Fibrinolytic activity in patients with diabetes mellitus: characterization of the effects of thrombolytic agents on plasma clot lysis in vitroR Fears, R Standring, R Abraham
Drugs|January 1, 1987
Evidence for the progressive uptake of anisoylated plasminogen streptokinase activator complex by clots in human plasma in vitroR Fears, H Ferres, R Standring
Drugs|January 1, 1987
The protective effect of acylation on the stability of anisoylated plasminogen streptokinase activator complex in human plasmaR Fears, H Ferres, R Standring
Thrombosis and Haemostasis|February 28, 1986
Isolation and preliminary characterisation of active B-chain of recombinant tissue-type plasminogen activatorI Dodd, R Fears, J H Robinson
Pageof 17